Federal Circuit Reverses, Says ‘Vimovo’ Patents Insufficiently Descriptive
WASHINGTON, D.C. — A New Jersey federal judge’s finding that two patents covering the pain-reliever drug “Vimovo” are adequately described under Section 112 of the Patent Act, 35 U.S.C. § 112,...To view the full article, register now.
Already a subscriber? Click here to view full article